Evidence map›Paper›PMID 34273998›Full record

ArticleGut pathogens2021

In silico molecular docking and in vitro antimicrobial efficacy of phytochemicals against multi-drug-resistant enteroaggregative Escherichia coli and non-typhoidal Salmonella spp.

Padikkamannil Abishad, Pollumahanti Niveditha, Varsha Unni, Jess Vergis, Nitin Vasantrao Kurkure, Sandeep Chaudhari, Deepak Bhiwa Rawool, Sukhadeo Baliram Barbuddhe

Open access · goldAbstract read
In one paragraph

Article in Gut pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 83 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Computational andBiomedical reports · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Padikkamannil AbishadDepartment of Veterinary Public Health, College of Veterinary and Animal Sciences, KVASU, 673 576, Pookode, Wayanad, India.
Pollumahanti NivedithaICAR-National Research Centre on Meat, Chengicherla, Boduppal Post, 500 092, Hyderabad, India.
Varsha UnniDepartment of Veterinary Public Health, College of Veterinary and Animal Sciences, KVASU, 673 576, Pookode, Wayanad, India.
Jess VergisDepartment of Veterinary Public Health, College of Veterinary and Animal Sciences, KVASU, 673 576, Pookode, Wayanad, India.
Nitin Vasantrao KurkureNagpur Veterinary College, MAFSU, Seminary Hills, 440 006, Nagpur, India.
Sandeep ChaudhariNagpur Veterinary College, MAFSU, Seminary Hills, 440 006, Nagpur, India.
Deepak Bhiwa RawoolICAR-National Research Centre on Meat, Chengicherla, Boduppal Post, 500 092, Hyderabad, India.
Sukhadeo Baliram BarbuddheICAR-National Research Centre on Meat, Chengicherla, Boduppal Post, 500 092, Hyderabad, India. barbuddhesb@gmail.com.ORCID http://orcid.org/0000-0002-6543-9757
ICAR - National Meat Research Institute · INKerala Veterinary and Animal Sciences University · INMaharashtra Animal and Fishery Sciences University · IN

Funding

Indian Council of Agricultural Research NASF/ABA-8007
6 · The paper itself

Abstract

backgroundIn the wake of emergence of antimicrobial resistance, bioactive phytochemical compounds are proving to be important therapeutic agents. The present study envisaged in silico molecular docking as well as in vitro antimicrobial efficacy screening of identified phytochemical ligands to the dispersin (aap) and outer membrane osmoporin (OmpC) domains of enteroaggregative Escherichia coli (EAEC) and non-typhoidal Salmonella spp. (NTS), respectively. MATERIALS AND

methodsThe evaluation of drug-likeness, molecular properties, and bioactivity of the identified phytocompounds (thymol, carvacrol, and cinnamaldehyde) was carried out using Swiss ADME, while Protox-II and StopTox servers were used to identify its toxicity. The in silico molecular docking of the phytochemical ligands with the protein motifs of dispersin (PDB ID: 2jvu) and outer membrane osmoporin (PDB ID: 3uu2) were carried out using AutoDock v.4.20. Further, the antimicrobial efficacy of these compounds against multi-drug resistant EAEC and NTS strains was determined by estimating the minimum inhibitory concentrations and minimum bactericidal concentrations. Subsequently, these phytochemicals were subjected to their safety (sheep and human erythrocytic haemolysis) as well as stability (cationic salts, and pH) assays.

resultsAll the three identified phytochemicals ligands were found to be zero violators of Lipinski's rule of five and exhibited drug-likeness. The compounds tested were categorized as toxicity class-4 by Protox-II and were found to be non- cardiotoxic by StopTox. The docking studies employing 3D model of dispersin and ompC motifs with the identified phytochemical ligands exhibited good binding affinity. The identified phytochemical compounds were observed to be comparatively stable at different conditions (cationic salts, and pH); however, a concentration-dependent increase in the haemolytic assay was observed against sheep as well as human erythrocytes.

conclusionsIn silico molecular docking studies provided useful insights to understand the interaction of phytochemical ligands with protein motifs of pathogen and should be used routinely before the wet screening of any phytochemicals for their antibacterial, stability, and safety aspects.

Indexed as

DockingEnteroaggregative E. coliNon-typhoidal SalmonellaPhytochemical

Identifiers

PMID34273998
PMCPMC8286599
OpenAlexW3185201115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.